Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
Rousselot
Philippe
P
Larghero
Jérome
J
Raffoux
Emmanuel
E
Calvo
Fabien
F
Tulliez
Michel
M
Giraudier
Stéphane
S
Rybojad
Michel
M
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate